This first Brazilian antigen and vaccine bank for foot-and-mouth disease represents a strategic stock of supplies aimed at the rapid formulation of vaccines in the event of localized outbreaks.
Savencia’s leadership says the move reinforces its long-standing presence in Brazil, where it has operated for decades with heritage names in the dairy sector.
The move is part of a strategic initiative aimed at boosting production capacity and streamlining logistics in response to increasing consumer demand nationwide.
The official launch took place in June at ExpoSuper 2025, the leading retail trade show and business convention in Santa Catarina.
The acquisition aligns with Piracanjuba’s national expansion strategy, leveraging the Northeast’s strong dairy industry and strategic geographic location.